285. ファンコニ貧血
[臨床試験数:56,薬物数:111(DrugBank:31),標的遺伝子数:30,標的パスウェイ数:151

Searched query = "Fanconi anemia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04483544
(ClinicalTrials.gov)
August 10, 202020/7/2020Pembrolizumab and Olaparib in Cervical Cancer PatientsImmunotherapy in Combination With PARP Inhibition in Advanced Cervical Cancer Patients Functionally Competent or Deficient for the Fanconi Anemia Repair PathwayCervical Cancer;Cervical CarcinomaDrug: pembrolizumab;Drug: olaparibBaptist Health South FloridaFlorida Department of Health;Merck Sharp & Dohme Corp.Recruiting18 YearsN/AFemale48Phase 2United States